About the study
- This study was funded by a grant awarded by the National Institute of Health Research (NIHR)
- The follow-up study is funded from three sources: a Cancer Research UK programme grant awarded to Professor Martin who is working with us on some of the follow-up data, an award from the Research and Innovation Department at University Hospitals Bristol, and Professor Ness' NIHR Senior Investigator Award.
- Researchers from Bristol University are leading the project and working with your local Head & Neck Team.
Background to Head and Neck 5000
- There are around 9,000 new cases of head and neck cancer diagnosed each year in the UK.
- The presence of additional illnesses unrelated to the tumour is high in people with head & neck cancer and can have a significant impact on their prognosis.
- The two-year all-cause mortality, a measure of the number of deaths (in general, or due to a specific cause), is around 35% and this has not improved until recently.
- Treatment for head & neck cancer is resource intensive because a person with head & neck cancer requires care from a range of disciplines.
- The incidence and survival is affected by the individuals’ socio-economic status.
- The centralisation of care to a smaller number of larger centres has implications for both people with head and neck cancer and their clinical team.